Clinical trials: Ritcher's Transformation, Syndrome

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small

Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer

• Approved For Marketing
• Age: 18 years and older
• Expanded access

This is an expanded access program for eligible participants with a previously treated B-cell cancer who are ineligible for an ongoing pirtobrutinib clinical trial.

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell, Waldenstrom Macroglobulinemia

Trial name

NCT05172700

Testing

Pirtobrutinib

Sponsor

Loxo Oncology, Inc.